Myocardial function in offspring 5-8years after pregnancy complicated by preeclampsia

Drude Fugelseth1, Heidi Bente Ramstad, Anne Stine Kvehaugen

  • 1Department of Neonatal Intensive Care, Oslo University Hospital, Ullevål, Oslo, Norway. drudefugelseth@hotmail.com

Insights

Children born after preeclampsia may experience negative heart effects by age 8. Preeclampsia is linked to smaller hearts and altered heart function in young children, suggesting long-term cardiovascular implications.

Area of Science:

  • Cardiology
  • Developmental Biology
  • Perinatology

Background:

  • Pregnancy complications like preeclampsia and diabetes share pathophysiological features.
  • These conditions may induce epigenetic changes affecting fetal development.
  • Such changes are linked to later metabolic and cardiovascular disease risks.

Purpose of the Study:

  • To investigate myocardial function in children exposed to pregnancy complications.
  • To compare cardiac outcomes in offspring of preeclamptic, diabetic, and uncomplicated pregnancies.

Main Methods:

  • Echocardiographic assessment of myocardial function in 45 children (5-8 years) born to mothers with preeclampsia, type 1 diabetes, or gestational diabetes.
  • Comparison with 15 children from uneventful pregnancies.
  • Utilized conventional Doppler and tissue Doppler imaging (TDI) for ventricular function analysis.

Main Results:

  • No significant overall differences in myocardial function between complication and control groups.
  • Preeclampsia group exhibited smaller heart size, increased heart rate, and elevated mitral A'-wave velocity compared to controls and diabetic groups.
  • Findings were consistent across pulsed wave and color TDI.

Conclusions:

  • Children born after preeclampsia may show early signs of cardiac impact by 5-8 years of age.
  • Preeclampsia appears to negatively affect heart development in offspring.
  • Further research with larger cohorts is warranted due to the limited sample size.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...